Article Details
Retrieved on: 2020-12-20 20:48:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Traditional engineered protein and monoclonal antibody drugs continue to account for a large percentage of new biologics under development, but ...
Article found on: www.technologynetworks.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here